5-(n-dodecanoyl)aminofluorescein has been researched along with rosiglitazone in 1 studies
| Studies (5-(n-dodecanoyl)aminofluorescein) | Trials (5-(n-dodecanoyl)aminofluorescein) | Recent Studies (post-2010) (5-(n-dodecanoyl)aminofluorescein) | Studies (rosiglitazone) | Trials (rosiglitazone) | Recent Studies (post-2010) (rosiglitazone) |
|---|---|---|---|---|---|
| 16 | 0 | 4 | 4,749 | 556 | 1,818 |
| Protein | Taxonomy | 5-(n-dodecanoyl)aminofluorescein (IC50) | rosiglitazone (IC50) |
|---|---|---|---|
| CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | 1.1 | |
| Bile salt export pump | Homo sapiens (human) | 4.5853 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 4.069 | |
| Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | 0.08 | |
| Thromboxane-A synthase | Homo sapiens (human) | 3.56 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.832 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.2481 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.038 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.048 | |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.048 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 5.1 | |
| CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | 2.29 | |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 0.731 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugelski, P; Elcock, F; Hahn, L; Hart, T; McFarland, D; Morgan, DG; Narayanan, PK; Schwartz, L; Zhang, C | 1 |
1 other study(ies) available for 5-(n-dodecanoyl)aminofluorescein and rosiglitazone
| Article | Year |
|---|---|
Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Membrane; Chromans; Coloring Agents; Dose-Response Relationship, Drug; Fibrinolytic Agents; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glutathione; Membrane Potentials; Mitochondria; Models, Chemical; Oxidative Stress; Oxygen; Phenanthridines; Propidium; Rats; Rosiglitazone; Superoxides; Thiazolidinediones; Troglitazone | 2003 |